Bellon Steven F. 4
4 · Foghorn Therapeutics Inc. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Bellon Steven F.
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-22$4.37/sh+140,000$611,800→ 140,000 totalExercise: $4.37Exp: 2035-01-21→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.